Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Patients experiencing persistent skin dryness, unusual texture changes, or delayed wound healing should discuss nutritional assessment with their healthcare provider, though a direct causal relationship between GLP-1 therapy and specific nutritional deficiencies has not been firmly established
doi: 10.4093/DMJ.2019.0208 27 ZhaoLZhuCLuMChenCNieXAbudukerimuBet al
Saraiva FK, Sposito AC
NistalaRHabibiJLastraGManriqueCAroorARHaydenMRet al
To view or add a comment, sign in Breakthrough Designation for Liver Disease TherapyThe landscape of metabolic health shifted significantly as the US FDA granted Breakthrough Therapy Designation to efimosfermin, a once-monthly investigational liver therapy targeting Metabolic Dysfunction-Associated Steatohepatitis (MASH) (My, 2026)
Bcl-xL expression decreased significantly after 6 h of TMQ0153 treatment in both U937 and MV4-11 cells (1.7- and 3.3-fold, respectively), indicating that Mcl-1 and Bcl-xL were regulated by cell death
US$ 27.16
US$ 28.45
US$ 20.40
US$ 23.77
US$ 20.18
